Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

The team investigated an IgE antibody called MOv18, exploring its ability to activate immune cells from patients at Guy’s and St Thomas’ NHS Foundation Trust with ovarian cancer and its influence on ...

Wei et al. examined the effect of IL-2 therapy on T REG cells in patients with ovarian cancer. On the basis of these results, the authors conclude that IL-2 induces the proliferation of T REG ...

New research has revealed how a novel IgE antibody (MOv18) therapy reactivates the immune cells of ovarian cancer patients, enabling them to fight the disease more effectively. Conducted by ...

AI analysis of cancer cells "We took over 61,000 images of cancer cells and fibroblasts treated with 528 different drugs. Then we used advanced computer programs to analyze the images and see how ...